Navigation Links
Globus Medical Launches NIKO(TM) Corpectomy Spacer System
Date:3/17/2008

New System Eliminates Assembly, Reduces Surgery Time

AUDUBON, Pa., March 17 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced the introduction of its NIKO(TM) Corpectomy Spacer System. The new system significantly reduces the time required for surgeons to perform multilevel corpectomies by offering an unprecedented array of interoperative options. It also extends Globus Medical's portfolio for trauma, tumor, and advanced degenerative disease solutions.

The NIKO(TM) Corpectomy Spacer System incorporates three saggital profiles within the implant system, each which contain at least nine preset heights. The resulting lordosis is contained in the endplate angles and within the shape of the implant itself, enabling surgeons to match the natural anatomy of the body. This feature allows NIKO(TM) to be immediately implanted, compared to multi-step competitive systems, by eliminating the assembly time of stackable cages or the cutting required with mesh cages.

"NIKO(TM) is an innovative approach to corpectomies, as it's simplicity saves interoperative time and the flexibility of preset options allows the surgeon to effectively treat the pathology. The system offers surgeons a straightforward alternative to mesh and stackable cages, while the elimination of interoperative implant alterations saves valuable time in the operating room. This is better for both surgeons and patients," said Dr. Nilesh Kotecha, MD, Neurosurgeon, Great Lakes Brain & Spine Institute, Jackson MI.

The addition of the NIKO(TM) Corpectomy Spacer enhances Globus Medical's product portfolio for meeting the clinical demands of spine surgery and specifically compliments the expandable and radiolucent XPand(R) R corpectomy cage. By meeting the demands of both routine and complex pathology, Globus Medical has an ability unmatched in the industry to serve the needs of surgeons who perform multilevel corpectomies due to trauma, tumors, and advanced degenerative disease.

"The ease-of-use and flexibility of NIKO(TM) reflects Globus Medical's superior engineering and commitment to advancing technology for the spine," said, Bill Rhoda, Director of Product Development, Intervertebral Fixation, "With NIKO(TM) and XPand (R) R, we continue to provide spine surgeons with a comprehensive portfolio of clinical solutions that are specifically designed to enhance surgical performance and improve patient outcomes."

About Globus Medical, Inc.

Globus Medical, Inc. is one of the ten largest spinal implant manufacturers in the world, with more than $120 million in annualized revenues. Based in Audubon, Pa., the privately held company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to employ both fusion and non- fusion solutions to promote healing in patients with spinal disorders. Globus Medical has a full portfolio of spinal fusion products, burgeoning initiatives in biomaterials development and minimally invasive approaches, and is among the world leaders in the development of motion sparing technology. Additional information can be accessed at http://www.globusmedical.com.


'/>"/>
SOURCE Globus Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Globus Medical Announces Record Revenue for 2007
2. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
3. XTend Medical (XMDC) Continues to Add Diabetic Patients to Telehealth Diabetic Program
4. Americas Top Pediatric Medical Institutions Unite to Drive Increased Federal Investment in Pediatric Research
5. Best of Show Awards Go to Spa and Medical Aesthetics Industry Stars
6. Customers Take Advantage of Loaner Kit Processing Services at Millstone Medical Outsourcings Memphis Facility
7. Leicester medical team announces predictor for pregnant women who may have miscarriages
8. Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare
9. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
10. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
11. Grubb & Ellis Healthcare REIT Acquires Fort Road Medical Building in St. Paul, Minnesota
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... 2017 , ... Golden Triangle Emergency Center will be hosting ... to commemorate the two-year anniversary of the facility. The event will feature refreshments ... years while also familiarizing themselves with the facility. , In the two years ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: